bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-71-3402

Order Name:
Foundation one-Heme, Tissue (FFPE) ** 

 
Useful For:
Assay for hematologic malignancies and sarcomas including but not limited to: Leukemias, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Lymphomas, Multiple Myeloma, Ewing Sarcoma, and Leiomyosarcoma.

Optimised for haematologic malignancies and sarcomas. Analyte TMB, MSI + PD-L1 + 406 genes (DNA) & 265 genes (RNA): Point mutations, insertions/deletions, copy number alterations, rearrangements
 
Methodology:
Next-generation sequencing (NGS)
 
AliasesName:
FoundationOne Heme, Tissue FFPE
Foundation test for Sarcomas
 
 
 
Test Code:
090-71-3402

Order Name:
Foundation one-Heme, Tissue (FFPE) ** 

 
Collection Specimen Or Container:
Tissue/ Formalin-fixed paraffin-embedded (FFPE) block

Document Required
Filled Requisition Form & Sign Consent of Referral Lab
 
Specimen Testing Type:
FFPE Block or 16 unstained slides (+ 1 H&E slide) FFPE tissue section serface area 5 x 5 mm² and dept ≥ 80 microns (Malignant cell content ≥ 20%, and ≥ 40% for liver specimens)
 
Sub Mission Container:
Specimen collection kit
 
Rejection Criteria:
Specimen was insufficient for testing (Insufficient amount of DNA, DNA highly fragmentation, Low of RNA quality)
 
 
 
Test Code:
090-71-3402

Order Name:
Foundation one-Heme, Tissue (FFPE) ** 

 
Method detail:
Next-generation sequencing (NGS)
 
Schedule:
N/A **Sent Out to Foundation Medicine, USA
 
Turnaround Time:
30-40 days (Slide received to report)
 
Performing Location:
FMI, Foundation Medicine
Referral Lab Services, Laboratory Department 14160-2
 
 
 
Test Code:
090-71-3402

Order Name:
Foundation one-Heme, Tissue (FFPE) ** 

 
 
Reference Value:
An interpretive report will be provided.
 
Interpretation:
Test results are provided directly to physicians in a report that highlights the genomic alterations and biomarkers present in a patient’s cancer and includes information to help inform clinical decision making. Everything in the report is supported by up-to-date clinical findings and scientific research.
 
Clinical Reference:
www.foundationmedicine.com (Retrieved: 15 Apr 2019)